Atogepant: The chief oral drug developed specifically for prophylactic treatment of episodic migraine

Authors

Abubakar Nazir
Mubarak Jolayemi Mustapha
Mahammed Khan Suheb, Advocate Aurora HealthFollow
et al

Recommended Citation

Nazir A, Jolayemi Mustapha M, Ahmed Ali U, et al. Atogepant: the chief oral drug developed specifically for prophylactic treatment of episodic migraine. IJS Global Health. 2023;6(4):e0220. doi:10.1097/GH9.0000000000000220

Affiliations

St. Luke's Aurora Hospital

Document Type

Letter